Fox Run Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Fox Run Management’s Portfolio ARQT Stock Details ARQT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$1.07M	Buy
2025 Q3	$544K	Buy
2025 Q2	$158K	Sell
2025 Q1	$469K	Buy
2024 Q4	$236K	Sell
2024 Q3	$180K	Sell
2024 Q2	$268K	Buy
2023 Q4	–	Sell
2023 Q3	$59.6K	Buy